Overview

Sofosbuvir in Treatment of COVID 19

Status:
Recruiting
Trial end date:
2021-08-31
Target enrollment:
Participant gender:
Summary
Sofosbuvir containing treatment in treatment of COVID 19 Egyptian patients
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Tanta University
Treatments:
Ribavirin
Sofosbuvir